BE616646A
(xx)
|
|
|
|
|
DE1124485B
(de)
|
1960-02-12 |
1962-03-01 |
Hoechst Ag |
Verfahren zur Herstellung von analeptisch wirksamen Phenylcycloalkylmethylaminen
|
GB1420472A
(en)
*
|
1972-09-27 |
1976-01-07 |
Pfizer |
Aminophenyltetralin compounds
|
US4045488A
(en)
*
|
1974-11-06 |
1977-08-30 |
Pfizer Inc. |
Aminophenyltetralin compounds
|
US4029731A
(en)
*
|
1974-11-06 |
1977-06-14 |
Pfizer Inc. |
Aminophenyltetralin compounds
|
JPS52133905A
(en)
*
|
1976-04-30 |
1977-11-09 |
Sumitomo Chem Co Ltd |
Preparation of enamides
|
DE2963572D1
(en)
*
|
1978-04-11 |
1982-10-21 |
Ciba Geigy Ag |
Mercapto-imidazole derivatives, their preparation, mercapto-imidazole derivatives for the treatment of inflammatory diseases and their pharmaceutical compositions
|
US4556676A
(en)
|
1979-11-01 |
1985-12-03 |
Pfizer Inc. |
Antidepressant derivatives of trans-4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine
|
ZA817261B
(en)
|
1980-10-23 |
1982-09-29 |
Schering Corp |
Carboxyalkyl dipeptides,processes for their production and pharmaceutical compositions containing them
|
US4540690A
(en)
|
1982-02-09 |
1985-09-10 |
The Upjohn Company |
2-(Phenylmethylene)cycloalkylamines and -azetidines
|
JPS58177915A
(ja)
|
1982-04-12 |
1983-10-18 |
Green Cross Corp:The |
抗血栓剤
|
WO1986000896A1
(en)
|
1984-07-30 |
1986-02-13 |
Schering Corporation |
NOVEL PROCESS FOR THE PREPARATION OF CIS, ENDOOCTAHYDROCYCLOPENTA ADb BDPYRROLE-2-CARBOXYLATE
|
DE3431541A1
(de)
|
1984-08-28 |
1986-03-06 |
Hoechst Ag, 6230 Frankfurt |
Cis,endo-2-azabicycloalkan-3-carbonsaeure-derivate, verfahren zu deren herstellung, deren verwendung sowie zwischenprodukte bei deren herstellung
|
US4738709A
(en)
|
1985-01-10 |
1988-04-19 |
Ppg Industries, Inc. |
Herbicidally active substituted benzisoxazoles
|
US4634703A
(en)
|
1985-10-25 |
1987-01-06 |
Bristol-Myers Company |
Method for alleviation of panic disorders
|
US4687772A
(en)
|
1986-10-07 |
1987-08-18 |
Bristol-Myers Company |
Method for improvement of short term memory
|
US4777173A
(en)
|
1987-03-25 |
1988-10-11 |
Bristol-Myers Company |
Method for treatment of alcohol abuse
|
US4751231A
(en)
|
1987-09-16 |
1988-06-14 |
Merck & Co., Inc. |
Substituted thieno[2,3-b]pyrrole-5-sulfonamides as antiglaucoma agents
|
JPH01172388A
(ja)
|
1987-12-25 |
1989-07-07 |
Sumitomo Chem Co Ltd |
チエノ〔3,2−b〕ピロロ〔2,3−d〕ピロール類およびその製法
|
JPH01172388U
(xx)
|
1988-05-24 |
1989-12-06 |
|
|
US5468749A
(en)
|
1988-08-30 |
1995-11-21 |
Gawin; Frank H. |
Method for treatment of substance addiction
|
US4981870A
(en)
|
1989-03-07 |
1991-01-01 |
Pfizer Inc. |
Use of 4-phenyl-1,2,3,4-tetrahydro-1-naphthalenamine derivatives in the treatment of psychosis, inflammation and as immunosuppressants
|
PT93943A
(pt)
|
1989-05-05 |
1991-02-08 |
Searle & Co |
Processo para a preparacao de composicoes contendo compostos indole-2-carboxilato para tratamento de perturbacoes do snc
|
ES2123500T3
(es)
|
1989-05-31 |
1999-01-16 |
Upjohn Co |
Derivados de 8-heterociclil-2-aminotetralina activos sobre el sistema nervioso central.
|
IL97054A
(en)
|
1990-02-12 |
1995-10-31 |
Bristol Meyers Squibb Co |
Pharmaceutical preparations containing bospirone for the treatment of coma
|
US5086054A
(en)
|
1990-07-31 |
1992-02-04 |
Sri International |
Novel arylcycloalkanepolyalkylamines
|
JPH04327532A
(ja)
|
1991-01-31 |
1992-11-17 |
Bristol Myers Squibb Co |
活動過剰を伴う注意力欠乏疾患の治療に使用する医薬製剤
|
US5858407A
(en)
|
1992-02-27 |
1999-01-12 |
Alza Corporation |
Method for administering tandospirone
|
GB9208492D0
(en)
|
1992-04-16 |
1992-06-03 |
Glaxo Spa |
Heterocyclic compounds
|
KR100263428B1
(ko)
|
1992-10-28 |
2000-11-01 |
나카노 가쓰히코 |
신규한1,2-벤조이속사졸유도체또는그의염,및이를포함하는뇌보호제
|
GB9304500D0
(en)
|
1993-03-05 |
1993-04-21 |
Glaxo Spa |
Heterocyclic compounds
|
ES2081747B1
(es)
|
1993-09-07 |
1997-01-16 |
Esteve Labor Dr |
Amidas derivadas de tienopirroles, su preparacion y su aplicacion como medicamentos.
|
GB9321221D0
(en)
|
1993-10-14 |
1993-12-01 |
Glaxo Spa |
Heterocyclic compounds
|
GB9326284D0
(en)
|
1993-12-23 |
1994-02-23 |
Erba Carlo Spa |
Pyrrolydenemethyl-derivatives and process for their preparation
|
HU225986B1
(en)
*
|
1994-01-10 |
2008-02-28 |
Teva Pharma |
Use of 1-aminoindan derivatives for preparing pharmaceutical compns. and 1-aminoindan derivatives
|
CN1047384C
(zh)
|
1994-07-28 |
1999-12-15 |
北京大学 |
雷米普利的合成方法
|
ATE253057T1
(de)
|
1994-08-30 |
2003-11-15 |
Sankyo Co |
Isoxazole
|
US5484763A
(en)
|
1995-02-10 |
1996-01-16 |
American Cyanamid Company |
Substituted benzisoxazole and benzisothiazole herbicidal agents
|
US5554383A
(en)
|
1995-04-06 |
1996-09-10 |
Trustees Of Tufts College |
Veterinary method for clinically modifying the behavior of dogs exhibiting canine affective aggression
|
US5620997A
(en)
|
1995-05-31 |
1997-04-15 |
Warner-Lambert Company |
Isothiazolones
|
US5859042A
(en)
|
1995-09-27 |
1999-01-12 |
Ono Pharmaceutical Co., Ltd. |
Five membered heterocyclic compounds
|
GB9617990D0
(en)
|
1996-08-29 |
1996-10-09 |
Scotia Holdings Plc |
Treatment of pain
|
DE19711785A1
(de)
|
1997-03-21 |
1998-09-24 |
Merck Patent Gmbh |
Endothelin-Rezeptor-Antagonisten
|
CA2289190A1
(en)
*
|
1997-05-07 |
1998-11-12 |
Algos Pharmaceutical Corporation |
Composition and method combining an antidepressant with an nmda receptor antagonist, for treating neuropathic pain
|
GB9717804D0
(en)
|
1997-08-22 |
1997-10-29 |
Zeneca Ltd |
Chemical compounds
|
AU9275498A
(en)
*
|
1997-10-03 |
1999-04-27 |
Chirotech Technology Limited |
Chiral amines
|
GB9803228D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
GB9803226D0
(en)
|
1998-02-17 |
1998-04-08 |
Zeneca Ltd |
Chemical compounds
|
JP2002507598A
(ja)
|
1998-03-26 |
2002-03-12 |
スージェン・インコーポレーテッド |
チロシン蛋白質キナーゼを調節するためのヘテロ環式化合物のファミリー
|
US6500827B2
(en)
|
1998-05-08 |
2002-12-31 |
Pharmacia & Upjohn Company |
Drug combinations
|
US6476078B2
(en)
|
1999-08-11 |
2002-11-05 |
Sepracor, Inc. |
Methods of using sibutramine metabolites in combination with a phosphodiesterase inhibitor to treat sexual dysfunction
|
US6632836B1
(en)
|
1998-10-30 |
2003-10-14 |
Merck & Co., Inc. |
Carbocyclic potassium channel inhibitors
|
GB9904786D0
(en)
|
1999-03-02 |
1999-04-28 |
Merck Sharp & Dohme |
Therapeutic agents
|
US6828460B2
(en)
|
1999-03-22 |
2004-12-07 |
Pfizer Inc. |
Resorcinol derivatives
|
US6245782B1
(en)
|
1999-05-17 |
2001-06-12 |
Heartdrug Research L.L.C. |
Methods of inhibiting platelet activation with selective serotonin reuptake inhibitors
|
FR2795733B1
(fr)
|
1999-06-30 |
2001-09-07 |
Aventis Pharma Sa |
Derives de streptogramines, leur preparation et les compositions qui les contiennent
|
EP1088824B1
(en)
|
1999-09-30 |
2004-01-07 |
Pfizer Products Inc. |
Bicyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
EP1391460A1
(en)
|
1999-09-30 |
2004-02-25 |
Pfizer Products Inc. |
Tricyclic pyrrolyl amides as glycogen phosphorylase inhibitors
|
US6846819B1
(en)
|
1999-10-08 |
2005-01-25 |
Affinium Pharmaceuticals, Inc. |
Fab I inhibitors
|
DE19960917A1
(de)
|
1999-12-17 |
2001-06-21 |
Bayer Ag |
Neue 3-Oxo-2,1-benzisoxazol-1(3H)-carboxamide zur Behandlung von ZNS-Erkrankungen
|
IN187170B
(xx)
|
2000-01-04 |
2002-02-23 |
Sun Pharmaceutical Ind Ltd |
|
US6632417B2
(en)
|
2000-03-07 |
2003-10-14 |
Chevron U.S.A. Inc. |
Process for preparing zeolites
|
JP2001247462A
(ja)
|
2000-03-07 |
2001-09-11 |
Otsuka Pharmaceut Co Ltd |
ウレアーゼ阻害剤
|
EP1136071A3
(en)
|
2000-03-22 |
2003-03-26 |
Pfizer Products Inc. |
Use of glycogen phosphorylase inhibitors
|
ATE269867T1
(de)
|
2000-04-19 |
2004-07-15 |
Kaneka Corp |
Neue azetidin-derivate und ein verfahren zur herstellung derselben
|
GB0012214D0
(en)
|
2000-05-19 |
2000-07-12 |
Merck Sharp & Dohme |
Therapeutic agents
|
JP2002020291A
(ja)
|
2000-06-30 |
2002-01-23 |
Sumitomo Pharmaceut Co Ltd |
認知機能障害の治療剤
|
WO2002012249A2
(en)
|
2000-08-04 |
2002-02-14 |
Eli Lilly And Company |
Substituted pyrrole compounds and their use as spla2 inhibitors
|
GB0021831D0
(en)
|
2000-09-06 |
2000-10-18 |
Astrazeneca Ab |
Chemical compounds
|
CA2424987A1
(en)
|
2000-10-06 |
2002-04-18 |
Smithkline Beecham Corporation |
Methods of agonizing and antagonizing fabk
|
TWI283575B
(en)
|
2000-10-31 |
2007-07-11 |
Eisai Co Ltd |
Medicinal compositions for concomitant use as anticancer agent
|
DE10063992A1
(de)
|
2000-12-21 |
2002-07-04 |
Max Planck Gesellschaft |
Tryptophan-Analoga in Proteinen, Peptiden und peptidischen Leitstrukturen
|
US6372919B1
(en)
|
2001-01-11 |
2002-04-16 |
Dov Pharmaceutical, Inc. |
(+)-1-(3,4-dichlorophenyl)-3-azabicyclo[3.1.0]hexane, compositions thereof, and uses as an anti-depressant agent
|
US20020123490A1
(en)
|
2001-03-01 |
2002-09-05 |
Pfizer Inc. |
Combination treatment for anxiety, depression, obsessive compulsive disorder and psychosis
|
US20020183306A1
(en)
|
2001-05-30 |
2002-12-05 |
Pfizer Inc. |
Combination treatment for sleep disorders including sleep apnea
|
WO2003000657A1
(fr)
|
2001-06-20 |
2003-01-03 |
Daiichi Pharmaceutical Co., Ltd. |
Derives de diamine
|
US6603000B2
(en)
*
|
2001-07-11 |
2003-08-05 |
Boehringer Ingelheim Pharmaceuticals, Inc. |
Synthesis for heteroarylamine compounds
|
JP4331595B2
(ja)
|
2001-08-09 |
2009-09-16 |
第一三共株式会社 |
ジアミン誘導体
|
US7045543B2
(en)
|
2001-11-05 |
2006-05-16 |
Enzrel Inc. |
Covalent conjugates of biologically-active compounds with amino acids and amino acid derivatives for targeting to physiologically-protected sites
|
US20030162825A1
(en)
|
2001-11-09 |
2003-08-28 |
Sepracor Inc. |
D-amino acid oxidase inhibitors for learning and memory
|
US6780891B2
(en)
|
2001-11-30 |
2004-08-24 |
Sepracor Inc. |
Tramadol analogs and uses thereof
|
KR100423875B1
(ko)
*
|
2001-12-06 |
2004-03-22 |
주식회사 포스코 |
키랄 아민의 제조 방법
|
TW200307539A
(en)
|
2002-02-01 |
2003-12-16 |
Bristol Myers Squibb Co |
Cycloalkyl inhibitors of potassium channel function
|
GB0205165D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
GB0205170D0
(en)
|
2002-03-06 |
2002-04-17 |
Astrazeneca Ab |
Chemical compounds
|
US6995144B2
(en)
|
2002-03-14 |
2006-02-07 |
Eisai Co., Ltd. |
Nitrogen containing heterocyclic compounds and medicines containing the same
|
WO2003091213A1
(fr)
|
2002-04-25 |
2003-11-06 |
Yamanouchi Pharmaceutical Co., Ltd. |
Derives d'amide ou sels de ces derives
|
AU2003236247A1
(en)
|
2002-05-03 |
2003-11-17 |
Warner-Lambert Company Llc |
Bombesin antagonists
|
JP2003335678A
(ja)
|
2002-05-17 |
2003-11-25 |
Sumitomo Pharmaceut Co Ltd |
神経因性疼痛治療薬
|
WO2004011459A1
(ja)
|
2002-07-31 |
2004-02-05 |
Mercian Corporation |
新規生理活性物質
|
ATE325125T1
(de)
|
2002-09-06 |
2006-06-15 |
Janssen Pharmaceutica Nv |
Thienopyrrolyl und furanopyrrolyl verbindungen und deren verwendung als histamin h4 rezeptor liganden
|
CN100584818C
(zh)
*
|
2002-09-16 |
2010-01-27 |
塞普拉科公司 |
用反式4-(3,4-二氯苯基)-1,2,3,4-四氢-1-萘胺及其甲酰胺治疗cns病症
|
US20040087661A1
(en)
|
2002-09-16 |
2004-05-06 |
Sepracor, Inc. |
Treatment of CNS disorders with trans 4-3(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-N-methyl-1-napthalenamine
|
US8134029B2
(en)
|
2002-09-16 |
2012-03-13 |
Sunovion Pharmaceuticals Inc. |
Treatment of CNS disorders with trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine
|
KR101067045B1
(ko)
|
2002-09-16 |
2011-09-22 |
선오비온 파마슈티컬스 인코포레이티드 |
트랜스 4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로-1-나프탈렌아민을 사용한 cns 장애의 치료
|
US20040106681A1
(en)
|
2002-10-03 |
2004-06-03 |
Cypress Bioscience, Inc. |
Dosage escalation and divided daily dose of anti-depressants to treat neurological disorders
|
US20040097554A1
(en)
|
2002-10-30 |
2004-05-20 |
Pfizer Inc |
Heteroaryl-hexanoic acid amide derivatives as immonomodulatory agents
|
BR0316099A
(pt)
|
2002-11-07 |
2005-09-27 |
Pfizer Prod Inc |
Agentes antidiabéticos
|
AU2004207731B2
(en)
|
2003-01-31 |
2009-08-13 |
Sanwa Kagaku Kenkyusho Co., Ltd. |
Compound inhibiting dipeptidyl peptidase iv
|
EP2239012A3
(en)
|
2003-04-11 |
2011-06-15 |
High Point Pharmaceuticals, LLC |
Substituted amide derivatives and pharmaceutical uses thereof
|
EP1633709A1
(en)
|
2003-04-30 |
2006-03-15 |
Pfizer Products Inc. |
Anti-diabetic agents
|
WO2004113345A1
(ja)
|
2003-06-20 |
2004-12-29 |
Japan Tobacco Inc. |
縮合ピロール化合物及びその医薬用途
|
ATE360638T1
(de)
|
2003-06-30 |
2007-05-15 |
Servier Lab |
Verfahren für die synthese von perindopril und seiner pharmazeutisch geeigneten salze
|
US7442804B2
(en)
|
2003-07-07 |
2008-10-28 |
Ciba Specialty Chemicals Corporation |
Process for the preparation of furopyrroles
|
KR20060073584A
(ko)
|
2003-07-29 |
2006-06-28 |
시그너쳐 알 앤드 디 홀딩스, 엘엘씨 |
아미노산 프로드럭
|
GB0318463D0
(en)
|
2003-08-07 |
2003-09-10 |
Astrazeneca Ab |
Chemical compounds
|
GB0319759D0
(en)
|
2003-08-22 |
2003-09-24 |
Astrazeneca Ab |
Chemical compounds
|
WO2005020986A1
(en)
|
2003-08-29 |
2005-03-10 |
Astrazeneca Ab |
Heterocyclic amide derivatives which posses glycogen phosphorylase inhibitory activity
|
GB0320422D0
(en)
|
2003-08-30 |
2003-10-01 |
Astrazeneca Ab |
Chemical compounds
|
US7396940B2
(en)
|
2003-10-23 |
2008-07-08 |
Hoffmann-La Roche Inc. |
Combinatorial library of 3-aryl-1H-indole-2-carboxylic acid
|
PT1420028E
(pt)
|
2003-11-19 |
2007-05-31 |
Servier Lab |
Processo de síntese do perindopril e dos seus sais farmacêuticamente aceitáveis.
|
EP1547997A1
(en)
*
|
2003-12-22 |
2005-06-29 |
Ppg - Sipsy |
New process for the synthesis of enamide derivatives
|
ZA200605383B
(en)
|
2003-12-29 |
2008-06-25 |
Sepracor Inc |
Pyrrole and pyrazole daao inhibitors
|
BRPI0417910A
(pt)
|
2003-12-29 |
2007-04-10 |
Sepracor Inc |
composto ou um sal ou salvato farmaceuticamente aceitáveis do mesmo, e, uso de um composto
|
EP1574498A1
(en)
*
|
2004-02-19 |
2005-09-14 |
PPG-Sipsy |
Process for the synthesis of substituted alpha-aminoindan derivatives
|
EP1746991A2
(en)
|
2004-03-16 |
2007-01-31 |
Janssen Pharmaceutica N.V. |
Daao inhibiting benzisoxazoles for treating mental disorders
|
ES2346665T3
(es)
|
2004-05-07 |
2010-10-19 |
Warner-Lambert Company Llc |
Derivados de fenol y tiofenol 3- o 4-monosustituidos utiles como ligandos de h3.
|
WO2006001958A2
(en)
|
2004-05-21 |
2006-01-05 |
Merck & Co., Inc. |
Amino cyclopentyl heterocyclic and carbocyclic modulators of chemokine receptor activity
|
KR100966749B1
(ko)
|
2004-05-26 |
2010-06-30 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
신나미드 화합물
|
WO2005123677A1
(en)
|
2004-06-16 |
2005-12-29 |
Actelion Pharmaceuticals Ltd |
4-carbonyl substituted 1,1,2-trimethyl-1a,4,5,5a-tetrahydro-1h-4-aza-cyclopropa'a!pentalene derivatives as agonists for the g-protein-coupled receptor s1p1/edg1 and immunosuppressive agents
|
RU2376309C2
(ru)
|
2004-07-01 |
2009-12-20 |
Асубио Фарма Ко., Лтд. |
Производное тиенопиразола, имеющее ингибирующую фосфодиэстеразу 7 (pde 7) активность
|
US7276631B2
(en)
|
2004-07-20 |
2007-10-02 |
Bristol-Myers Squibb Company |
Cyclopentylamine and cyclohexylamine derivatives as NK-1/SSRI antagonists
|
JO2629B1
(en)
|
2004-08-19 |
2012-06-24 |
افينتيس فارما سوتيكالز انك |
Branched carboxylic acid amides containing thienobirol, carboxylic acid amides containing pyrolithiazole, and the like as kinase inhibitors casein epsilon
|
US20080262071A1
(en)
|
2004-09-17 |
2008-10-23 |
Timothy Dinan |
Pindolol for the Treating Premenstrual Syndrome and Premenstrual Dysphoric Disorder
|
CA2594665A1
(en)
|
2005-01-19 |
2006-07-27 |
Biolipox Ab |
Thienopyrroles useful in the treatment of inflammation
|
CN100391945C
(zh)
|
2005-05-31 |
2008-06-04 |
浙江大学 |
一种s-(-)-吲哚啉-2-羧酸的合成方法
|
WO2007006003A2
(en)
*
|
2005-07-06 |
2007-01-11 |
Sepracor Inc. |
Combinations of eszopiclone and trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-n-methyl-1-napthalenamine or trans 4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydro-1-napthalenamine, and methods of treatment of menopause and mood, anxiety, and cognitive disorders
|
ZA200800500B
(en)
*
|
2005-07-12 |
2009-04-29 |
Anceris |
Use of 4-(3,4 dichloro-phenyl)-1,2,3,4-tetrahydro-naphtalen-1-ylamine for treating cancer
|
JP2009511462A
(ja)
|
2005-10-06 |
2009-03-19 |
メルク シャープ エンド ドーム リミテッド |
D−アミノ酸酸化酵素阻害剤として神経変性および精神疾患を治療するための縮合ピロールカルボン酸の使用
|
UA95788C2
(xx)
|
2005-12-15 |
2011-09-12 |
Ф. Хоффманн-Ля Рош Аг |
Конденсовані похідні піролу$кондесированные производные пиррола
|
WO2007081542A2
(en)
|
2006-01-06 |
2007-07-19 |
Sepracor Inc. |
Tetralone-based monoamine reuptake inhibitors
|
RU2430913C2
(ru)
|
2006-01-06 |
2011-10-10 |
Сепракор Инк. |
Циклоалкиламины в качестве ингибиторов повторного поглощения моноамина
|
DK2013835T3
(en)
|
2006-03-31 |
2015-12-14 |
Sunovion Pharmaceuticals Inc |
Preparation of chiral amides and AMINES
|
KR20090015089A
(ko)
|
2006-05-31 |
2009-02-11 |
세프라코 아이엔시. |
트랜스 4-(3,4-디클로로페닐)-1,2,3,4-테트라하이드로-1-나프탈렌아민 및 그의 포름아미드에 의한 통증장애 치료방법
|
US7579370B2
(en)
|
2006-06-30 |
2009-08-25 |
Sepracor Inc. |
Fused heterocycles
|
US7884124B2
(en)
|
2006-06-30 |
2011-02-08 |
Sepracor Inc. |
Fluoro-substituted inhibitors of D-amino acid oxidase
|
JP2009542683A
(ja)
|
2006-06-30 |
2009-12-03 |
セプラコア インコーポレーテッド |
D−アミノ酸オキシダーゼの縮合ヘテロ環式阻害剤
|
US20080058395A1
(en)
|
2006-06-30 |
2008-03-06 |
Sepracor Inc. |
Fused heterocyclic inhibitors of D-amino acid oxidase
|
CN1962656A
(zh)
|
2006-11-29 |
2007-05-16 |
沈阳药科大学 |
吲哚美辛5-氟尿嘧啶甲酯药用化合物及其制剂和制备方法
|
FR2909376A1
(fr)
*
|
2006-11-30 |
2008-06-06 |
Cerep Sa |
Procedes de preparation de la desmethulsertraline ou d'un de ses sels pharmaceutiquement acceptables
|
CA2676432A1
(en)
|
2007-01-18 |
2008-07-24 |
Sepracor, Inc. |
Inhibitors of d-amino acid oxidase
|
US7902252B2
(en)
|
2007-01-18 |
2011-03-08 |
Sepracor, Inc. |
Inhibitors of D-amino acid oxidase
|
BRPI0811639A2
(pt)
|
2007-05-31 |
2014-09-30 |
Sepracor Inc |
Cicloaquilaminas fenil substituídas como inibidores da recaptação de monoamina
|
US20100120740A1
(en)
|
2008-08-07 |
2010-05-13 |
Sepracor Inc. |
Prodrugs of fused heterocyclic inhibitors of d-amino acid oxidase
|